Common use of Healthcare Compliance Matters Clause in Contracts

Healthcare Compliance Matters. (a) Except as set forth on Section 4.21(a) of the Company Disclosure Schedule (i) each Company Group Member is in compliance and since January 1, 2017 has been in compliance with all Health Care Laws applicable to such Company Group Member or any assets owned or used by it and (ii) no Company Group Member has received any written communication or has been subject to any Proceeding (other than routine FDA inspections) since January 1, 2017 from a Governmental Entity that alleges that such Company Group Member is not in compliance with any Health Care Law, except in the case of the immediately foregoing clauses (i) and (ii) where any non-compliance has not had and would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect. Except as set forth on Section 4.21(a) of the Company Disclosure Schedule, (i) no Company Group Member is party to and has any ongoing obligations pursuant to or under any corporate integrity agreements, deferred prosecution agreements, monitoring agreements, consent decrees, settlement orders, plans of correction or similar agreements with or imposed by any Governmental Entity, and (ii) no Company Group Member or any of its employees, officers or directors has been excluded, suspended or debarred from participation in any U.S. state or federal health care program or, to the Knowledge of the Company, has been convicted of any crime or is subject to any Proceeding by any Governmental Entity or other similar action, or has engaged in any conduct, that could reasonably be expected to result in debarment, suspension, or exclusion.

Appears in 2 contracts

Samples: Plan Funding Agreement (Amryt Pharma PLC), Plan Funding Agreement (Novelion Therapeutics Inc.)

AutoNDA by SimpleDocs

Healthcare Compliance Matters. (a) Except as set forth on Section 4.21(a) 5.21 of the Company Plan Investor Disclosure Schedule (i) each Company Plan Investor Group Member is in compliance and since January 1, 2017 has been in compliance with all Health Care Laws applicable to such Company Plan Investor Group Member or any assets owned or used by it and (ii) no Company Plan Investor Group Member has received any written communication or has been subject to any Proceeding (other than routine FDA inspections) since January 1, 2017 from a Governmental Entity that alleges that such Company Plan Investor Group Member is not in compliance with any Health Care Law, except in the case of the immediately foregoing clauses (i) and (ii) where any non-compliance has not had and would not reasonably be expected to have, individually or in the aggregate, a Company Plan Investor Material Adverse Effect. Except as set forth on Section 4.21(a) 5.21 of the Company Plan Investor Disclosure Schedule, (i) no Company Plan Investor Group Member is party to and has any ongoing obligations pursuant to or under any corporate integrity agreements, deferred prosecution agreements, monitoring agreements, consent decrees, settlement orders, plans of correction or similar agreements with or imposed by any Governmental Entity, and (ii) no Company Plan Investor Group Member or any of its employees, officers or directors has been excluded, suspended or debarred from participation in any U.S. state or federal health care program or, to the Knowledge of the CompanyPlan Investor, has been convicted of any crime or is subject to any Proceeding by any Governmental Entity or other similar action, or has engaged in any conduct, that could reasonably be expected to result in debarment, suspension, or exclusion.

Appears in 2 contracts

Samples: Plan Funding Agreement (Amryt Pharma PLC), Plan Funding Agreement (Novelion Therapeutics Inc.)

AutoNDA by SimpleDocs

Healthcare Compliance Matters. (a) Except as set forth on Section 4.21(a) of the Company Disclosure Schedule (i) Boat and each Company Group Member is of its Subsidiaries are in compliance and since January 1, 2017 has 2015 have been in compliance with all Health Care Laws applicable to such Company Group Member Boat or any of its Subsidiaries or any assets owned or used by it any of them and (ii) no Company Group Member neither Boat nor any of its Subsidiaries has received any written communication or has been subject to any Proceeding (other than routine FDA inspections) since January 1, 2017 2015 from a Governmental Entity that alleges that such Company Group Member Boat or any of its Subsidiaries is not in compliance with any Health Care Law, except in the case of the immediately foregoing clauses (i) and (ii) where any non-compliance compliance, individually or in the aggregate, has not had and would not reasonably be expected to have, individually or in the aggregate, a Company Boat Material Adverse Effect. Except as set forth on Section 4.21(a) Neither Boat nor any of the Company Disclosure Schedule, (i) no Company Group Member its Subsidiaries is a party to and or has any ongoing obligations pursuant to or under any corporate integrity agreements, deferred prosecution agreements, monitoring agreements, consent decrees, settlement orders, plans of correction or similar agreements with or imposed by any Governmental Entity. Additionally, and (ii) no Company Group Member none of Boat, its Subsidiaries or any of its respective employees, officers or directors has been excluded, suspended or debarred from participation in any U.S. state or federal health care program or, to the Knowledge of the CompanyBoat, has been convicted of any crime or is subject to any Proceeding by any Governmental Entity a governmental inquiry, investigation, Proceeding, or other similar action, or has engaged in any conduct, that could reasonably be expected to result in debarment, suspension, or exclusion.

Appears in 1 contract

Samples: Agreement and Plan of Merger (Biocryst Pharmaceuticals Inc)

Time is Money Join Law Insider Premium to draft better contracts faster.